Related Experiment Videos

The relation between familial Mediterranean fever and amyloidosis

G Grateau1

  • 1Service de médecine interne, L'Hôtel-Dieu, Paris, France.

Insights

Familial Mediterranean fever (FMF) is a hereditary fever. Daily colchicine prevents attacks and amyloidosis, but M694V mutation is linked to persistent amyloidosis, causing kidney failure.

Area of Science:

  • Genetics
  • Rheumatology
  • Nephrology

Background:

  • Familial Mediterranean fever (FMF) is the most common hereditary recurrent fever syndrome.
  • Reactive amyloidosis is the most severe complication of FMF, leading to chronic kidney failure.
  • Colchicine treatment is effective but does not fully eradicate FMF-associated amyloidosis.

Purpose of the Study:

  • To investigate the genetic basis of FMF and its association with amyloidosis.
  • To explore the role of specific MEFV gene mutations in the development of the amyloid phenotype.

Main Methods:

  • Genetic analysis of patients with FMF.
  • Association studies between MEFV gene mutations and the occurrence of amyloidosis.

Main Results:

  • Discovery of the Mediterranean fever gene (MEFV) as the cause of FMF.
  • Identification of a strong association between the M694V mutation and the amyloid phenotype in FMF patients.

Conclusions:

  • The MEFV gene and its mutations are crucial in FMF pathogenesis.
  • The M694V mutation is a significant risk factor for developing amyloidosis in FMF.
  • Further research is needed to fully understand and manage FMF-associated amyloidosis.

Related Concept Videos